Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats

Transplant Proc. 2001 Feb-Mar;33(1-2):183-4. doi: 10.1016/s0041-1345(00)01967-9.

Authors

H Echizenya¹, K Yamashita, M Takehara, K Konishi, M Nomura, N Yanagida, N Kitagawa, T Kobayashi, H Furukawa, M Inobe, T Uede, S Todo

Affiliation

¹ First Department of Surgery, Hokkaido University, School of Medicine, Sapporo, Japan.

PMID: 11266771
DOI: 10.1016/s0041-1345(00)01967-9

No abstract available

MeSH terms

Abatacept
Adenoviridae / genetics
Animals
Antigens, CD
Antigens, Differentiation / blood
Antigens, Differentiation / therapeutic use*
B7-1 Antigen / drug effects*
CD28 Antigens / drug effects*
CTLA-4 Antigen
Genetic Therapy / methods*
Genetic Vectors / therapeutic use*
Graft Rejection / blood
Graft Rejection / prevention & control
Immunoconjugates*
Immunoglobulin G / therapeutic use*
Immunosuppressive Agents / blood
Immunosuppressive Agents / therapeutic use*
Intestine, Small / transplantation*
Male
Rats
Rats, Inbred Lew

Substances

Antigens, CD
Antigens, Differentiation
B7-1 Antigen
CD28 Antigens
CTLA-4 Antigen
Immunoconjugates
Immunoglobulin G
Immunosuppressive Agents
Abatacept